Gary Milne
Contributor since: 2016
Sequans Q3: Another Bitter Pill For Investors
Sequans: A Look At Q2 And Beyond
Herbalife: Boosting Sales Leader Retention In Sagging Markets
Herbalife Q3: Huge Issues Exposed By FTC Order
Herbalife: A Preview Of Q3 In North America
Evaluating Sequans' Lead In IoT Chips
Herbalife: The Frantic Effort To Fill The U.S. Recruitment Gap
Herbalife: When An EPS Raise Isn't Really A Raise
Herbalife: A Preview Of Q2 In North America
Sequans: The Opportunity Ahead
Herbalife Q1: Not So Good
How Herbalife Fooled Wall Street With Its Preferred Member Numbers
ORBCOMM: The Stars Align In 2017
Trouble Ahead At Axon
Herbalife: The Google Trends Data That Spell Trouble Ahead
Sequans: 10 More Reasons To Add This Internet Of Things Company To Your Portfolio
Shake-O-Nomics: Debunking The Myth Of The Herbalife Discount Only Member
Why You Should Sell Sierra Wireless, And What To Buy Instead
Sequans: 10 Reasons To Invest In This Internet Of Things Company
Does Herbalife Have Its Finger On The Scales?
Orbcomm: Devices + Network + Apps = Internet Of Things
TASER International: Projections For Q3 Revenue And Earnings
Taser International Q2 Earnings: A Turning Point
Taser International: 3 Reasons Why The Axon Segment Losses Are About To Start Shrinking
Taser International: A Tale Of 2 Businesses